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IS KIR HAPLOTYPE MATCHING IMPORTANT?
Gendzekhadze, K.1, Oki, A.1, Shen, Y.2, Palmer, J.2, Nademanee, A.3,
Nakamura, R.3, Forman, S.3, Senitzer, D.1 1City of Hope, Duarte, CA;
2City of Hope, Duarte, CA; 3City of Hope, Duarte, CA
KIR haplotypes and their Centromeric (Cen) and Telomeric (Tel)
motifs have been shown to affect HCT outcome for unrelated donor
donor transplantation in AML patients. Little is known regarding
KIR haplotype matching. HLA and KIR segregate independently.
Only 25% of sibling donors were expected to be KIR fully matched
with the patient. Our pilot study included 108 AML patients trans-
planted in complete remission at City of Hope (2005-2009).
Table. Patient Demographic and Clinical Characteristics
N or medianPatient Female/Male ratio 60/48
Donor Type Bone Marrow/Stem Cell 24/84
1st/2nd/3d remission 87/19/2
Survival / Death 69/39
Disease Progrsseion / No 44/64
Relapse / No 29/64
Death without relapse 15
aGVHD / No 56/52
cGVHD / No 61/47The patient and HLA-fully matched sibling donor were typed for
KIR genes and 3DL1 alleles (SSP-Multiplex). We sequenced 3DL1/
3DS1 alleles and Ig domains for 3DL2 and 3DL3 genes. A KIR-fully
matched pair is defined patient and donor share the same KIR geno-
type, have identical 3DL1/S1 alleles, and the same SNP for 3DL2
and 3DL3.
24 (22%) patients had KIR fully matched donors. Interestingly, if
the patient and sibling had identical Bx KIR genotypes, then their
3DL1 alleles or 3DL2/3 SNP were also identical, with only few ex-
ceptions (8/28), which is not true for AA patient/donor combination
(14/18 AA pairs). The data appears to confirm that KIR B haplotypes
are less diverse in terms of KIR alleles than KIR A haplotypes.
Therefore, if the patient and sibling are identical based on KIR
Bx genotypes, most probably they are KIR fully matched (70%
probability).
Patients with fully matched KIR donors have similar relapse and
aGVHD rates however, disease free survival is slightly higher (RR5
0.553; 95%CI5 0.23-1.3; P5NS). Patients with KIR Bx donor ge-
notype have a higher incidence of aGVHD (RR 5 1.96; 95%
CI 5 1.03-2.73; p 5 0.04), due to Tel-Bx motif (RR 5 2.06; 95%
CI5 1.2-3.5; p 5 0.009). Higher donor B content is associated with
increased aGVHD (RR 5 1.94; 95%CI 5 1.12-3.34; p 5 0.018).
Non of those parameters had any impact on rates of relapse, or
disease-free survival.
In conclusion, KIR haplotype matching does not appear to affect
related HCT outcome. However, KIR B haploype was associated
with aGVHD. These results suggest that inclusion of ALL patients
may reveal greater impact of the KIR genes on HCT.185
THE IMPACT OF SINGLE CLASS I HLA-ANTIGEN MISMATCH ON OUTCOME
OF CHILDREN UNDERGOING HEMATOPOIETIC CELL TRANSPLANTATION
FROM RELATED DONORS
Ayas, M., Al-Seraihy, A., Siddiqui, K., Al-Jefri, A., Al-Ahmari, A.,
Khairi, A., Shaheen, H., Markiz, S., El-Solh, H. King Faisal Specialist
Hospital & Research Center, Riyadh, Saudi Arabia
Several studies have shown that single class I HLA-antigen mis-
matches adversely affect the outcome of hematopoietic cell trans-
plantation (HCT) from unrelated donors. Few data are however
available on the significance of such mismatch in related donor
HCT, particularly in children. This study was designed to retrospec-
tively compare the outcomes of children who underwent HCT fromHLA class I single antigen mismatched related donors and children
who underwent HCT from fully matched related donors.
Patients andMethods: 38 patients (pts), age#14 years, underwent
HCT from HLA class I single antigen mismatched related donors
from January 1993 to December 2010 at King Faisal Specialist Hos-
pital & Research Center. Out of this group, 30 pts (the study group:
MIS) were matched with 90 pts that underwent HCT from fully
matched related donors (the control group: MRD) with respect to
age, gender, donor gender, indication for HCT, donor relationship
and source of stem cells.
Results: There were 18 males in MIS and 55 in MRD (P 5 1.00).
Median age at HCT was 2.1 years in MIS and 4.5 years in MRD
(P5 0.4). The locus of mismatch was A in 22 pts and B in 8 pts. Me-
dian follow up time was 5.7 years (95% CI: 2.5-8.8) in MIS and 4.6
years (95% CI: 2.9-6.4) in MRD. Incidence of Acute graft vs. host
disease (aGVHD) was 63% (19 pts) in MIS and 35% (32 pts) in
MRD (P5 0.01), and the incidence of severe (grade III-IV) aGVHD
was 33.3% (10 pts) and 9% (8 pts) in the 2 groups (P 5 0.007). One
hundred pts were evaluable for chronic graft vs.host disease
(cGVHD), 23 in MIS and 77 in MRD. Incidence of cGVHD was
26.1% (6 pts) in MIS and 6.5% (5 pts) in MRD (P5 0.017). Among
MIS, 13% (3 pts) experienced extensive cGVHD in contrast to 3.9%
(3 pts) inMRD (P5 0.029). Incidence ofGraft Failure (Primary/sec-
ondary) was not different in the 2 groups; 40% (12 pts) in MIS com-
pared to 27.8% (25 pts) in MRD (P 5 0.26). No significant
difference was found between the overall survival (OS) of the pts
from MIS (55%) and MRD (38%) (P 5 0.072). However, pts in
MRD had a significantly better Event Free Survival (EFS) of 32%
compared to 21% in MIS (P 5 0.027); events were defined as pri-
mary/secondary graft failure, relapse of primary disease, or death.
Conclusion:Our analysis demonstrates that in related donor HCT,
a single antigen, HLA-class I mismatch is associated with a signifi-
cantly higher risk of acute and chronic GVHD, and with a lower sur-
vival when compared with HCT from fully matched related donors.186
GENETIC ANCESTRY: AN ALTERNATIVE TO SELF-IDENTIFIED RACE AND
ETHNICITY FOR THE EVALUATION OF UNRELATED TRANSPLANTATION
OUTCOMES
Madbouly, A.1, Gragert, L.1, Malkki, M.2, Petersdorf, E.2, Maiers, M.1
1NationalMarrowDonor Program,Minneapolis, MN; 2FredHutchinson
Cancer Research Center, Seattle, WA
Weare investigating genetic ancestry in transplant pairs as ameans
to understand differences in outcomes across ethnic groups and also
as a potentially informative new parameter of matching.
Genetic ancestry of transplanted patient/donor pairs was analyzed
using two types of ancestry informative markers (AIMs): HLA and
SNPs. The dataset included 491 individuals (76 African-American
(AFA), 48 Asian/Pacific Islanders (API), 243 Caucasian (CAU), 104
Hispanic (HIS) and 20 Native American (NAM)) genotyped for
HLA-A, -B, -C, -DRB1 and -DQB1 and 30 autosomal SNPs from
a published (Nassir 2009) reference AIMs panel. 23 of the chosen
SNPs had .40% allele frequency difference between AFA and
CAU, 23.40% difference between AFA and API, and 9.40% dif-
ference between CAU and API. Out of the last 9 SNPs, only one had
a difference .40% between CAU and South Asian (SAS) and three
between East Asian (EAS) and SAS. Assignment of admixture pro-
portions was determined using STRUCTURE v2.3.2. Preliminary
results recaptured ancestry of self-identified AFA, EAS and CAU in-
dividuals, however distinguishing SAS fromCAU individuals proved
challenging due to sample size disparities and the lack of sufficiently
differentiating SNPs. When the pilot cohort was augmented with
EAS and SAS individuals from the published reference cohort
(Nassir 2009) to balance sample proportions, SAS individuals
emerged as a separate cluster distinct from EAS and CAU.
We additionally used Bayesian inference to assign racial categories
to the pilot cohort using HLA AIMs. The algorithm used reference
haplotype frequencies and knowledge of population sizes within the
Be TheMatch Registry as priors to calculate the overall likelihood
of a race assignment. Classifying race using HLA frequencies gave
.80% recovery of self-identified race for AFA and API, with lower
recovery for CAU, HIS, and NAM. HLA ancestry classification is
used as a supplement to ancestry classification using SNP AIMs.
